Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 28, 2016 - Issue sup1: 2015 AIDS Impact Conference Supplement
5,676
Views
58
CrossRef citations to date
0
Altmetric
Articles

Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial

, , , , , , , , , , , , & show all
Pages 48-55 | Received 07 Oct 2015, Accepted 20 Jan 2016, Published online: 17 Feb 2016

Figures & data

Table 1. Main characteristics of the study sample participants at baseline (ANRS IPERGAY trial, n = 400).

Figure 1. Condom and/or PrEP use reported during the last sexual intercourse (ANRS IPERGAY trial, n = 320 participants with at least one analyzable questionnaire between M2 and M24, corresponding to 1212 sexual intercourse analyzed). Low exposure: anal sex with condoms or oral sex; high exposure: condomless anal sex. *Total: corresponds to the number of sexual intercourses analyzed among the 320 participants between M2 and M24. **Trends were tested for each category: low exposure with PrEP (p = .49); low exposure without PrEP (p = .38); high exposure with PrEP (p = .18); high exposure without PrEP (p = .86).

Figure 1. Condom and/or PrEP use reported during the last sexual intercourse (ANRS IPERGAY trial, n = 320 participants with at least one analyzable questionnaire between M2 and M24, corresponding to 1212 sexual intercourse analyzed). Low exposure: anal sex with condoms or oral sex; high exposure: condomless anal sex. *Total: corresponds to the number of sexual intercourses analyzed among the 320 participants between M2 and M24. **Trends were tested for each category: low exposure with PrEP (p = .49); low exposure without PrEP (p = .38); high exposure with PrEP (p = .18); high exposure without PrEP (p = .86).

Figure 2. Use of PrEP, reported during the last anal sexual intercourse (ANRS IPERGAY trial, n = 259 participants with at least one analyzable questionnaire between M2 and M24; all of them reported at least on recent episode of anal sexual intercourse protected by PrEP use, corresponding to 731 anal sexual intercourses analyzed). PrEP correct use: according to protocol or taking at least 1 pill within 24 h before and 1 pill within 24 h after sex; PrEP suboptimal use: taking at least 1 pill 48 h before or 48 h after sex. *Total: corresponds to the number of anal sexual intercourses protected by using PrEP analyzed among the 259 participants between M2 and M24. **Trends were tested for each category: suboptimal use (p = .50); correct use (p = .50).

Figure 2. Use of PrEP, reported during the last anal sexual intercourse (ANRS IPERGAY trial, n = 259 participants with at least one analyzable questionnaire between M2 and M24; all of them reported at least on recent episode of anal sexual intercourse protected by PrEP use, corresponding to 731 anal sexual intercourses analyzed). PrEP correct use: according to protocol or taking at least 1 pill within 24 h before and 1 pill within 24 h after sex; PrEP suboptimal use: taking at least 1 pill 48 h before or 48 h after sex. *Total: corresponds to the number of anal sexual intercourses protected by using PrEP analyzed among the 259 participants between M2 and M24. **Trends were tested for each category: suboptimal use (p = .50); correct use (p = .50).

Figure 3. Evolution of median number of sexual intercourse (A), sexual partners (B), condomless last insertive or receptive anal intercourse (C), and condomless last RAI (D) over time (ANRS IPERGAY trial, n = 400 participants).

Figure 3. Evolution of median number of sexual intercourse (A), sexual partners (B), condomless last insertive or receptive anal intercourse (C), and condomless last RAI (D) over time (ANRS IPERGAY trial, n = 400 participants).